Grant DoD, CD24 Tumor-Initiating Cell as a Novel Therapeutic Target in Myeloma, was awarded to Dr. Fenghuang Zhan’s team. Dr. Zhan is the Principle Investigator and Partnering PI is Dr. Gail Bishop.
Date:
Tuesday, June 25, 2019
Grant DoD, CD24 Tumor-Initiating Cell as a Novel Therapeutic Target in Myeloma, was awarded to Dr. Fenghuang Zhan’s team. Dr. Zhan is the Principle Investigator and Partnering PI is Dr. Gail Bishop.